|Biotech Due Diligence||
A holiday-shortened week that was not short on news and analysis in the world of biotech on Twitter. Enjoy the latest edition of the Biotech Tweets of the Week, curated by @23aloha and @BioDueDiligence.
Thanks for your interest - be sure to read all the to the final tweet for an exceptional homage to the 9/11 anniversary we recognize today.
$ACRX $AKBA $AXON $BLUE $BMRN $ECYT $FLXN $GSK $ONCE $SRPT $THRX $TTPH #WCLC2015 and more $BXI $IBB
The dog days of summer have been a crazy 3 weeks in the markets and for biotech in particular. Catch up on all the action with a curated collection of the highlights from the biotech / pharma discussion on Twitter curated by @23aloha and @BioDueDiligence.
Triple Play Biotech Tweets of the Week (August 17-21, August 24-28, August 31 - September 4, 2015)
Week 1: $KITE $ESPR $VRX Addyi
Week 2: Flash Crash $SRPT $AMGN PCSK9
Week 3: $ALNY $MDCO $FOLD $TRVN $ARIA $ACAD
And much more from around the world of $XBI $IBB, science / medicine / drug development.
The great links just keep coming, so enjoy an extra edition of the Biotech Reading List while you await the return of the Tweets of the Week on Friday September 4!
If you are enjoying some shockingly mild August weather like us here in the Washington DC area, feel free to bookmark this latest collection of recommended reading for the biotech enthusiast and read another day!
Patients clamor to get into trials for immunotherapy, the new frontier in cancer treatment
Todd Ackerman (Houston Chronicle)
Patient Death Does Not Augur Doom, But Kite Pharma Needs To Shut Its Big Mouth
Matthew Herper (Forbes) $KITE
A shattering crash, an online chronicle, and an unexpected twist: In the age of social media, patients who test experimental treatments wield surprising clout
Rebecca Robbins (STAT / Boston Globe) $NVIV
Dr. Frances Kelsey: American Hero, Government Regulator
Stewart Lyman (Xconomy) - on the death of one of the FDA's most well-known employees. $CELG
-A terrific companion read is the "Autobiographical Reflections" of Dr. Kelsey published by the FDA.
How The FDA Works: A Primer For The Novice Biotech Investor
David Sable (Forbes)
Your support is greatly appreciated